Announced Mon, 29 Jun · 15:52 IST
Trading window closes from July 1 ahead of Q1 FY27 results
Compliance View source PDF
JUBLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+2.4%1-day move
₹955.00
prior close
₹960.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.3-0.3-0.1-0.6+2.4+1.8+1.5+3.0+2.8+1.9+5.2———
Up moveDown movePending
AI summary
Jubilant Pharmova has closed its trading window from July 1, 2026 until 48 hours after the announcement of unaudited financial results for Q1 FY27 (quarter ending June 30, 2026). Designated persons and their immediate relatives are barred from trading in company shares during this period. The board meeting date for the results will be communicated later. This is a routine compliance filing under SEBI insider trading rules.
Likely market impact
Routine compliance filing with no direct impact. Signals upcoming Q1 FY27 results announcement that could move the stock.